Suppr
超能文献

Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptide.

作者信息

Sima Anders A F

机构信息

Departments of Pathology and Neurology, Wayne State University School of Medicine, Detroit, MI 48201, USA.

出版信息

J Neurol Sci. 2004 May 15;220(1-2):133-6. doi: 10.1016/j.jns.2004.03.014.

DOI:10.1016/j.jns.2004.03.014

PMID:15140622

Abstract

摘要

相似文献

Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptide.

J Neurol Sci. 2004 May 15;220(1-2):133-6. doi: 10.1016/j.jns.2004.03.014.

[Physiological effects of C-peptide].

Nephrologie. 2004;25(5):155-61.

C-peptide, Na+,K(+)-ATPase, and diabetes.

Exp Diabesity Res. 2004 Jan-Mar;5(1):37-50. doi: 10.1080/15438600490424514.

Type 1 diabetic neuropathy and C-peptide.

Exp Diabesity Res. 2004 Jan-Mar;5(1):65-77. doi: 10.1080/15438600490424541.

Effects of C-peptide on microvascular blood flow and blood hemorheology.

Exp Diabesity Res. 2004 Jan-Mar;5(1):51-64. doi: 10.1080/15438600490424532.

C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy.

Diabetes Care. 2007 Jan;30(1):71-6. doi: 10.2337/dc06-1274.

[Maurice Dérot Prize 2004. Should C-peptide be put in the insulin bottle?].

Journ Annu Diabetol Hotel Dieu. 2004:231-7.

C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats.

Diabetes Metab Res Rev. 2007 Jan;23(1):63-70. doi: 10.1002/dmrr.672.

C-peptide as a therapeutic tool in diabetic nephropathy.

Am J Nephrol. 2010;31(5):389-97. doi: 10.1159/000289864. Epub 2010 Mar 31.

Electrolytes and NA(+)-K(+)-ATPase: potential risk factors for the development of diabetic nephropathy.

Pak J Pharm Sci. 2008 Apr;21(2):172-9.

引用本文的文献

Peripheral Neuropathy Phenotyping in Rat Models of Type 2 Diabetes Mellitus: Evaluating Uptake of the Neurodiab Guidelines and Identifying Future Directions.

Diabetes Metab J. 2022 Mar;46(2):198-221. doi: 10.4093/dmj.2021.0347. Epub 2022 Mar 24.

Minocycline alleviates nociceptive response through modulating the expression of NR2B subunit of NMDA receptor in spinal cord of rat model of painful diabetic neuropathy.

J Diabetes Metab Disord. 2021 Jun 3;20(1):793-803. doi: 10.1007/s40200-021-00820-4. eCollection 2021 Jun.

Non-glucose risk factors in the pathogenesis of diabetic peripheral neuropathy.

Endocrine. 2020 Dec;70(3):465-478. doi: 10.1007/s12020-020-02473-4. Epub 2020 Sep 7.

Nutrient excess and altered mitochondrial proteome and function contribute to neurodegeneration in diabetes.

Mitochondrion. 2011 Nov;11(6):845-54. doi: 10.1016/j.mito.2011.06.007. Epub 2011 Jul 2.

Mitochondrial stress and the pathogenesis of diabetic neuropathy.

Expert Rev Endocrinol Metab. 2010 Jan 1;5(1):39-49. doi: 10.1586/eem.09.55.

The beneficial effects of C-Peptide on diabetic polyneuropathy.

Rev Diabet Stud. 2009 Fall;6(3):187-202. doi: 10.1900/RDS.2009.6.187. Epub 2009 Nov 10.

Abnormal calcium homeostasis in peripheral neuropathies.

Cell Calcium. 2010 Feb;47(2):130-9. doi: 10.1016/j.ceca.2009.11.008. Epub 2009 Dec 24.

The effects of C-peptide on type 1 diabetic polyneuropathies and encephalopathy in the BB/Wor-rat.

Exp Diabetes Res. 2008;2008:230458. doi: 10.1155/2008/230458.

C-peptide is a bioactive peptide.

Diabetologia. 2007 Mar;50(3):503-9. doi: 10.1007/s00125-006-0559-y. Epub 2007 Jan 18.

Early diabetic neuropathy: triggers and mechanisms.

World J Gastroenterol. 2007 Jan 14;13(2):175-91. doi: 10.3748/wjg.v13.i2.175.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptide.

J Neurol Sci. 2004 May 15;220(1-2):133-6. doi: 10.1016/j.jns.2004.03.014.

[Physiological effects of C-peptide].

Nephrologie. 2004;25(5):155-61.

C-peptide, Na+,K(+)-ATPase, and diabetes.

Exp Diabesity Res. 2004 Jan-Mar;5(1):37-50. doi: 10.1080/15438600490424514.

Type 1 diabetic neuropathy and C-peptide.

Exp Diabesity Res. 2004 Jan-Mar;5(1):65-77. doi: 10.1080/15438600490424541.

Effects of C-peptide on microvascular blood flow and blood hemorheology.

Exp Diabesity Res. 2004 Jan-Mar;5(1):51-64. doi: 10.1080/15438600490424532.

C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy.

Diabetes Care. 2007 Jan;30(1):71-6. doi: 10.2337/dc06-1274.

[Maurice Dérot Prize 2004. Should C-peptide be put in the insulin bottle?].

Journ Annu Diabetol Hotel Dieu. 2004:231-7.

C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats.

Diabetes Metab Res Rev. 2007 Jan;23(1):63-70. doi: 10.1002/dmrr.672.

C-peptide as a therapeutic tool in diabetic nephropathy.

Am J Nephrol. 2010;31(5):389-97. doi: 10.1159/000289864. Epub 2010 Mar 31.

Electrolytes and NA(+)-K(+)-ATPase: potential risk factors for the development of diabetic nephropathy.

Pak J Pharm Sci. 2008 Apr;21(2):172-9.

引用本文的文献

Peripheral Neuropathy Phenotyping in Rat Models of Type 2 Diabetes Mellitus: Evaluating Uptake of the Neurodiab Guidelines and Identifying Future Directions.

Diabetes Metab J. 2022 Mar;46(2):198-221. doi: 10.4093/dmj.2021.0347. Epub 2022 Mar 24.

Minocycline alleviates nociceptive response through modulating the expression of NR2B subunit of NMDA receptor in spinal cord of rat model of painful diabetic neuropathy.

J Diabetes Metab Disord. 2021 Jun 3;20(1):793-803. doi: 10.1007/s40200-021-00820-4. eCollection 2021 Jun.

Non-glucose risk factors in the pathogenesis of diabetic peripheral neuropathy.

Endocrine. 2020 Dec;70(3):465-478. doi: 10.1007/s12020-020-02473-4. Epub 2020 Sep 7.

Nutrient excess and altered mitochondrial proteome and function contribute to neurodegeneration in diabetes.

Mitochondrion. 2011 Nov;11(6):845-54. doi: 10.1016/j.mito.2011.06.007. Epub 2011 Jul 2.

Mitochondrial stress and the pathogenesis of diabetic neuropathy.

Expert Rev Endocrinol Metab. 2010 Jan 1;5(1):39-49. doi: 10.1586/eem.09.55.

The beneficial effects of C-Peptide on diabetic polyneuropathy.

Rev Diabet Stud. 2009 Fall;6(3):187-202. doi: 10.1900/RDS.2009.6.187. Epub 2009 Nov 10.

Abnormal calcium homeostasis in peripheral neuropathies.

Cell Calcium. 2010 Feb;47(2):130-9. doi: 10.1016/j.ceca.2009.11.008. Epub 2009 Dec 24.

The effects of C-peptide on type 1 diabetic polyneuropathies and encephalopathy in the BB/Wor-rat.

Exp Diabetes Res. 2008;2008:230458. doi: 10.1155/2008/230458.

C-peptide is a bioactive peptide.

Diabetologia. 2007 Mar;50(3):503-9. doi: 10.1007/s00125-006-0559-y. Epub 2007 Jan 18.

Early diabetic neuropathy: triggers and mechanisms.

World J Gastroenterol. 2007 Jan 14;13(2):175-91. doi: 10.3748/wjg.v13.i2.175.

Suppr超能文献

Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptide.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译